Suchergebnisse - "Kim, Hak Hee"

PubPharm (304)

1

Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations

enthalten in: European radiology | 2024

von Kim, H. | Kim, H. | Kim, K. | +6

2

High-resolution diffusion-weighted MRI plus mammography for detecting clinically occult breast cancers in women with dense breasts

enthalten in: European journal of radiology | 2024

von Kim, H. | Shin, H. | Baek, S. | +6

3

Prediction of the MammaPrint Risk Group Using MRI Features in Women With Estrogen Receptor-Positive, HER2-Negative, and 1 to 3 Node-Positive Invasive Breast Cancer

enthalten in: Clinical breast cancer | 2024

von Kim, H. | Choi, W. | Cha, J. | +3

4

Assessing internal mammary lymph node metastasis by breast magnetic resonance imaging in breast cancer

enthalten in: Medicine | 2023

von Cho, S. | Cha, J. | Kim, H. | +5

5

Improving mammography interpretation for both novice and experienced readers : a comparative study of two commercial artificial intelligence software

enthalten in: European radiology | 2023

von Kim, H. | Choi, W. | Gwon, H. | +5

6

Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)

enthalten in: Breast cancer research and treatment | 2023

von Hwang, I. | Kim, J. | Jeong, J. | +8

7

Correlation of shear-wave elastography parameters with the molecular subtype and axillary lymph node status in breast cancer

enthalten in: Clinical imaging | 2023

von Kim, H. | Kim, H. | Choi, W. | +3

8

Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Kang, S. | Lee, S. | Lee, H. | +10

9

Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)

enthalten in: Breast cancer research and treatment | 2023

von Hwang, I. | Kim, J. | Jeong, J. | +8

10

Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)

enthalten in: Breast cancer research and treatment | 2023

von Hwang, I. | Kim, J. | Jeong, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]